What is Prime Medicine's accrued manufacturing costs?

Prime Medicine (PRME) reported accrued manufacturing costs of $2.19M in Q1 2026.

How has Prime Medicine's accrued manufacturing costs changed year-over-year?

Prime Medicine's accrued manufacturing costs decreased by 47.6% year-over-year, from $4.18M to $2.19M.

What is the long-term trend for Prime Medicine's accrued manufacturing costs?

Over 4 years (2021 to 2025), Prime Medicine's accrued manufacturing costs has grown at a 32.7% compound annual growth rate (CAGR), from $2.36M to $7.34M.

Prime Medicine PRME Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Eli LillyLLY

——

Sana BiotechnologySANA

——

Opus GeneticsIRD

——

Immix Biopharma, Inc.IMMX

——

PrecigenPGEN

——

Viridian Therapeutics, Inc.VRDN

——

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's accrued manufacturing costs?: Prime Medicine (PRME) reported accrued manufacturing costs of $2.19M in Q1 2026.
How has Prime Medicine's accrued manufacturing costs changed year-over-year?: Prime Medicine's accrued manufacturing costs decreased by 47.6% year-over-year, from $4.18M to $2.19M.
What is the long-term trend for Prime Medicine's accrued manufacturing costs?: Over 4 years (2021 to 2025), Prime Medicine's accrued manufacturing costs has grown at a 32.7% compound annual growth rate (CAGR), from $2.36M to $7.34M.